openPR Logo
Press release

Ulcerative Colitis Market to Incur Fortitude Growth During 2018-2026 by Global Top Players - AbbVie Inc., Hospira, Celltrion Healthcare, Johnson and Johnson, F. Hoffmann-La Roche AG, Warner Chilcott, Janssen Pharmaceuticals Inc. and Takeda Pharmaceuticals

09-10-2018 04:47 PM CET | Health & Medicine

Press release from: CMI - Pharmaceutical Industry

Ulcerative Colitis Market

Ulcerative Colitis Market

Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained weight loss, loss of appetite, joint pain, eye disease, thickening of the intestinal wall, blood infection (sepsis), kidney stones and liver disease. The diagnosis of this disease can be carried out by physical examination using tests such as colonoscopy, endoscopy, biopsy, CT scan and blood test.

If ulcerative colitis persists for over 8 years or longer, it may lead to colon cancer. The people having mild symptoms of this disease can be cured by over the counter drugs such as Imodium therapy. However, transcription medicine such as steroid medicines and amino salicylates are widely used to treat the condition. In severe cases, the patient may need to undergo surgery to remove the colon, which also helps prevent colon cancer.

Request Sample Copy of Ulcerative colitis Market Report : https://www.coherentmarketinsights.com/insight/request-sample/238

Also, some genetically engineered drugs also used to treat ulcerative colitis. These drugs are made up of certain living organisms that help suppress the inflammation, by targeting the inflammatory proteins such as cytokines. Some genetically engineered drugs approved by the U.S. FDA for treatment of the condition are Adalimumab (Humira), Golimumab (Simponi), Infliximab (Remicade) and Vedolizumab (Entyvio).

These genetically engineered drugs may show some side effects such as fever, headache, hives, low blood pressure, breathing difficulties, back pain, and stomach pain. Also, these drugs may affect the immunity power of body to fight infection.

The exact cause for ulcerative colitis is unknown, though possible reasons are may be genetic factors, environmental changes, or weakened immune system. The ulcerative colitis can be prevented by simple healthy habits such as eating small meals throughout the day, staying well hydrated throughout the day, avoiding fatty foods, and limiting intake of high-fiber food.

According to data released by the Centers for Disease Control and Prevention (CDC), there are around 2.2 to 14.3 cases found per 100,000 population per year. Also, according to a study conducted in 2014 by Crohn’s & Colitis Foundation of America (CCFA), 907,000 people suffered from ulcerative colitis in the U.S. (data based on the research conducted in between 2011-2014 by CCFA)

Browse Brief Report, Click Here: https://www.coherentmarketinsights.com/ongoing-insight/ulcerative-colitis-market-238

Ulcerative colitis market taxonomy:

Global Market by Drug Type

Infliximab
Golimumab
Adalimumab
Vedolizumab
Mesalamine
Budesonide
Balsazide

Global Market by Dosage Form

Parenteral
Oral

Global Market by Geography

North America
Europe
APAC
Latin America
Middle East
Africa

Else place an Inquire before Purchase “ Global Ulcerative Colitis Market Size, Status and Forecast Report 2026": https://www.coherentmarketinsights.com/insight/talk-to-analyst/238

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ulcerative Colitis Market to Incur Fortitude Growth During 2018-2026 by Global Top Players - AbbVie Inc., Hospira, Celltrion Healthcare, Johnson and Johnson, F. Hoffmann-La Roche AG, Warner Chilcott, Janssen Pharmaceuticals Inc. and Takeda Pharmaceuticals here

News-ID: 1230881 • Views:

More Releases from CMI - Pharmaceutical Industry

Empty Capsules Market to Surpass US$ 2.79 Billion Threshold by 2025 Globally | Leading Players ACG Associated Capsules Pvt. Ltd., Capsugel, Inc., CapsCanada Corporation, Medicaps Ltd., Qualicaps, Inc., JC Biological Technology Co., Patheon, Inc., Roxlor L
Empty Capsules Market to Surpass US$ 2.79 Billion Threshold by 2025 Globally | L …
The Global Empty Capsules Market by Product Type (Gelatin Capsules (Porcine, Bovine, and Bone Meal), Non-Gelatin Capsules (HPMC and Pullulan)), By Application (Antibiotics, Vitamins, Anti-Inflammatory, Anti-Anemic and Others), By End User (Pharmaceutical Manufacturers, Nutraceutical Manufacturers and Others), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 1.55 billion in 2016 and is projected to exhibit a CAGR of 7.7% over the
Significant Number of Pipeline Drugs to Surge Hereditary Angioedema Market beyond US$ 3.4 Billion by 2025 | Top Players CSL Behring, Shire Plc., Pharming Healthcare, Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Arrowhead Pharmaceutic
Significant Number of Pipeline Drugs to Surge Hereditary Angioedema Market beyon …
The Global Hereditary Angioedema Market, by Drug Class (C1 Esterase Inhibitor, Kallikrein Inhibitor, Bradykinin Receptor, Attenuated Androgens, and Others), by Route of Administration (Subcutaneous, Intravenous, and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 1,563.7 million in 2016 and is projected to exhibit a CAGR of 9.1% over the
PD-1 and PDL-1 Inhibitors Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
PD-1 and PDL-1 Inhibitors Market - Global Industry Insights, Trends, Outlook, an …
Targeted cancer therapy is the primary objective of extensive research related to cancer drugs. Our immune cells are programmed to attack the foreign cell on activation. PD-1 and PDL-1 are among those activation points present on the immune cells. Sometimes cancer cells also use this PD-1 and PDL-1 trigger points to avoid being attacked by the immune cells. Therefore, cancer drugs targeting these cells hold tremendous potential in the cancer
Dermal Regeneration Template Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Dermal Regeneration Template Market - Global Industry Insights, Trends, Outlook, …
Dermal regeneration template is a two-layered skin regeneration system. The outer layer of dermal regeneration template is made of thin silicone film act as the epidermis of skin. The outer layer of dermal regeneration template helps in protecting wound from infection and controls in loss of both heat and moisture. The outer collagen Glycosaminoglycan (GAG) thermal layer functions as a biodegradable template that helps in regeneration of dermal tissue neodermis

All 5 Releases


More Releases for Ulcerative

Ulcerative Colitis Pipeline Insights Report | DelveInsight
DelveInsight's, "Ulcerative Colitis Pipeline Insight" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ulcerative Colitis Pipeline Landscape. It covers the Ulcerative Colitis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Ulcerative Colitis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay
Novel Therapies for Ulcerative Colitis Patients
"The Business Research Company recently released a comprehensive report on the Global Ulcerative Colitis Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The ulcerative colitis market size
Ulcerative Colitis Market - Breaking Barriers, Transforming Digestive Health: Ul …
Newark, New Castle, USA: The "Ulcerative Colitis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Ulcerative Colitis Market: https://www.growthplusreports.com/report/ulcerative-colitis-market/8815 This latest report researches the industry structure, sales, revenue,
Ulcerative Colitis Market - Breaking Barriers, Empowering Resilience: Transformi …
Newark, New Castle, USA - new report, titled Ulcerative Colitis Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ulcerative Colitis market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ulcerative Colitis market. The report offers an overview of the market, which
Ulcerative Colitis - Drug Pipeline Landscape, 2023
Global Ulcerative Colitis Market report from Global Insight Services is the single authoritative source of intelligence on ulcerative colitis market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,
Ulcerative Colitis Market
Ulcerative colitis is the most common type of inflammatory bowel disease that affects the colon (lining of the large intestine) and rectum. The inflammation produces tiny sores called ulcers. These disease can affect people of any age, though prevalence is especially high among people under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps, bleeding from the rectum, also other indications are sudden and unexplained